Literature DB >> 16129104

Update on disparities in the pathophysiology and management of hypertension: focus on African Americans.

Crystal A Gadegbeku1, Janice P Lea, Kenneth A Jamerson.   

Abstract

Hypertension treatment and control is of paramount importance in the prevention of premature cardiovascular disease. African Americans present a special challenge to the clinician due, in part, to their earlier age of onset,greater prevalence, and increased rates of untoward events. A review of the recent studies of genetic epidemiology has not revealed unique genotypes that explain human hypertension or the disparate impact suffered by African Americans. Moreover, a clear message has emerged that environmental factors predominate in their effect on cardiovascular risk and are mutable. These findings suggest that to have an immediate and substantial impact on the ethnic disparity of hypertension, resources and research should be directed toward social and behavioral factors. Prompt and aggressive control of blood pressure is an effective global strategy for cardiovascular risk reduction. In most cases, this approach requires multiple interventions including lifestyle modification and an antihypertensive regimen that is tailored to the individual under the current guidelines and not stipulated by race.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16129104     DOI: 10.1016/j.mcna.2005.05.003

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  17 in total

1.  The Association of Neighborhood Gene-Environment Susceptibility with Cortisol and Blood Pressure in African-American Adults.

Authors:  Sandra M Coulon; Dawn K Wilson; M L Van Horn; Gregory A Hand; Stephen Kresovich
Journal:  Ann Behav Med       Date:  2016-02

Review 2.  Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review.

Authors:  Ina U Park; Anne L Taylor
Journal:  Ann Fam Med       Date:  2007 Sep-Oct       Impact factor: 5.166

Review 3.  Cardiovascular health disparities: a systematic review of health care interventions.

Authors:  Andrew M Davis; Lisa M Vinci; Tochi M Okwuosa; Ayana R Chase; Elbert S Huang
Journal:  Med Care Res Rev       Date:  2007-10       Impact factor: 3.929

4.  Multilevel Associations of Neighborhood Poverty, Crime, and Satisfaction With Blood Pressure in African-American Adults.

Authors:  Sandra M Coulon; Dawn K Wilson; Kassandra A Alia; M Lee Van Horn
Journal:  Am J Hypertens       Date:  2015-04-27       Impact factor: 2.689

5.  Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients.

Authors:  David J Taber; Kelly J Hunt; Cory E Fominaya; Elizabeth H Payne; Mulugeta Gebregziabher; Titte R Srinivas; Prabhakar K Baliga; Leonard E Egede
Journal:  Hypertension       Date:  2016-07-11       Impact factor: 10.190

Review 6.  Social Determinants of Racial Disparities in CKD.

Authors:  Jenna M Norton; Marva M Moxey-Mims; Paul W Eggers; Andrew S Narva; Robert A Star; Paul L Kimmel; Griffin P Rodgers
Journal:  J Am Soc Nephrol       Date:  2016-05-13       Impact factor: 10.121

Review 7.  Sleep as a potential fundamental contributor to disparities in cardiovascular health.

Authors:  Chandra L Jackson; Susan Redline; Karen M Emmons
Journal:  Annu Rev Public Health       Date:  2015-03-18       Impact factor: 21.981

Review 8.  Disparities in amputations in minorities.

Authors:  Kristin M Lefebvre; Lawrence A Lavery
Journal:  Clin Orthop Relat Res       Date:  2011-07       Impact factor: 4.176

9.  Social support buffering of the relation between low income and elevated blood pressure in at-risk African-American adults.

Authors:  S M Coulon; D K Wilson
Journal:  J Behav Med       Date:  2015-07-09

10.  Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).

Authors:  Martin Brunner; Rhonda M Cooper-DeHoff; Yan Gong; Jason H Karnes; Taimour Y Langaee; Carl J Pepine; Julie A Johnson
Journal:  Am J Cardiol       Date:  2007-04-16       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.